Inventor · disambiguated record
Eike Staub
Also filed as: STAUB EIKE
7 granted patents·3 pending applications·7 citations·filing 2012–2022
76Inventor score
Top patents by PatentIndex Score
10 records- 0184US11306146B2Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseasesMERCK PATENT GMBH·Filed 2019·Granted Apr 19, 2022·2 cites·16 claims
- 0278US10435472B2Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseasesMERCK PATENT GMBH·Filed 2015·Granted Oct 8, 2019·3 cites·23 claims
- 0376US11485786B2Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2019·Granted Nov 1, 2022·1 cites·15 claims
- 0474US11851492B2Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseasesMERCK PATENT GMBH·Filed 2022·Granted Dec 26, 2023·0 cites·16 claims
- 0571US12054549B2Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2022·Granted Aug 6, 2024·0 cites·9 claims
- 0669US2022334117A1Method of treating solid cancers and/or metastases thereof, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereofMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 0760US9249114B2Thiazole derivativesKARRA SRINIVASA R·Filed 2012·Granted Feb 2, 2016·1 cites·14 claims
- 0852US11415581B2Method of treating solid cancers and/or metastases thereof with pan AV integrin inhibitor, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereofMERCK PATENT GMBH·Filed 2015·Granted Aug 16, 2022·0 cites·6 claims
- 0950US2016215348A1Gene expression biomarkers and their use for diagnostic and prognostic application in patients potentially in need of hdac inhibitor treatment4SC AG·Filed 2014·Application pending·0 cites
- 1047US2019144547A1Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eike Staub files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →